ライフサイエンスコーパス: platelet-derived

1 activation of the receptor tyrosine kinases, platelet-derived and epidermal growth factor receptors.

2 increased sensitivity to neutrophil killing, platelet-derived antimicrobials in serum, and the cathel

3 Here, we identified platelet-derived Dickkopf-1 (Dkk1) as the major Wnt anta

4 Therefore, platelet-derived disulfide HMGB1 is a central mediator o

5 Interestingly, platelet-derived excess soluble CD40 ligand found in the

6 The plasma platelet-derived exosome number is lower and its chemoki

7 endothelial cell-derived exosomes (EDEs) and platelet-derived exosomes (PDEs) were precipitated and e

8 A new method for isolation of plasma platelet-derived exosomes is described and used to exami

9 Cargo proteins of human plasma platelet-derived exosomes may biomark platelet abnormali

10 Platelet-derived exosomes mediate platelet atherogenic i

11 ly suppressed cargo protein levels of plasma platelet-derived exosomes without altering total levels

12 Plasma platelet-derived exosomes, enriched by absorption with m

13 Human plasma platelet-derived exosomes: effects of aspirin.

14 individual completely devoid of plasma- and platelet-derived factor V (FV) identified 167 variants i

15 Through these interactions, platelet-derived factors can contribute to the proinflam

16 The postoperative profile of circulating platelet-derived factors correlates with the ability of

17 l clipping if animals had greater than 2% of platelets derived from 2bF8LV-transduced hCB cells, wher

18 onor platelets, we found marked differences: platelets derived from infused megakaryocytes closely re

19 s individual, its effects on his plasma- and platelet-derived FV concentrations were assessed.

20 hat in an individual with normal plasma- and platelet-derived FV concentrations.

21 In marked contrast, release of the patient's platelet-derived FV/Va (7% of normal) following platelet

22 In contrast, increased platelet-derived FV/Va concentrations were observed with

23 l, thereby highlighting the critical role of platelet-derived FV/Va in ensuring hemostatic competence

24 expression in human platelets and that human platelet-derived FVIII can improve hemostasis in hemophi

25 Both plasma- and platelet-derived FXIIIa were susceptible to plasmin-medi

26 early to initiate neovessel formation while platelet-derived GF (PDGF-BB) is needed later to stabili

27 tion of matrix-associated GFs, TGF-beta, and platelet-derived GF to GF(-) or culture supernatants.

28 The Platelet Derived Growth Factor (PDGF) family of ligands

29 Platelet derived growth factor (PDGF) plays a pivotal ro

30 Platelet derived growth factor receptor alpha (PDGFRalph

31 Interstitial cells, known as platelet derived growth factor receptor alpha (PDGFRalph

32 oma cells, including increased expression of platelet derived growth factor receptor beta (PDGFRB) me

33 ent of known imatinib targets including Abl, platelet derived growth factor receptor beta (PDGFRbeta)

34 ascular endothelial growth factor) and PDGF (platelet derived growth factor).

35 is a milieu of bioactive factors, including platelet derived growth factor, transforming growth fact

36 ession of the spliced XBP1 or treatment with platelet derived growth factor-BB up-regulated miR-150 e

37 tors such as tumor necrosis factor-alpha and platelet derived growth factor-BB were also found to inc

38 Many signaling pathways, including platelet- derived growth factor (PDGF)-AA/alphaalpha, ar

39 Prostaglandin E2, platelet-derived growth factor (PDGF) AA, eotaxin, vascu

40 Platelet-derived growth factor (PDGF) acts through two c

41 to delineate the transcriptional response to platelet-derived growth factor (PDGF) and fibroblast gro

42 rum response factor (SRF) is induced by both platelet-derived growth factor (PDGF) and fibroblast gro

43 We find that fibroblasts treated with platelet-derived growth factor (PDGF) and prepolarized b

44 Expression of both platelet-derived growth factor (PDGF) and vascular endot

45 e involved in the lipopolysaccharide-induced platelet-derived growth factor (PDGF) and Wnt signaling

46 10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, admini

47 Using these platforms, 10 pM platelet-derived growth factor (PDGF) are detected withi

48 d apoptotic priming, we examined the role of platelet-derived growth factor (PDGF) in CAF priming for

49 Platelet-derived growth factor (PDGF) is a mitogen and c

50 rowth factors, the most representative being platelet-derived growth factor (PDGF) isoforms (PDGF-AA,

51 We also provided evidence that platelet-derived growth factor (PDGF) plays a substantia

52 ied KCE method to an experimental model of a platelet-derived growth factor (PDGF) protein and its DN

53 The platelet-derived growth factor (PDGF) receptor (PDGFR) f

54 While platelet-derived growth factor (PDGF) receptor alpha (PD

55 The platelet-derived growth factor (PDGF) receptors (PDGFRs)

56 Activation of the c-kit and platelet-derived growth factor (PDGF) receptors by autoc

57 ascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors, has sin

58 -of-function alterations leading to enhanced platelet-derived growth factor (PDGF) signaling are comm

59 Enhanced platelet-derived growth factor (PDGF) signaling in gliom

60 Inhibition of foxc1 perturbed platelet-derived growth factor (Pdgf) signaling, impairi

61 ng a small interfering RNA (siRNA) targeting platelet-derived growth factor (PDGF) was used to allevi

62 Platelet-derived growth factor (PDGF), a potent mitogen

63 clotted wound by a concentration gradient of platelet-derived growth factor (PDGF), together with oth

64 In vitro platelet-derived growth factor (PDGF)- and tumor necrosi

65 Here, we show that platelet-derived growth factor (PDGF)-B/PDGF receptor be

66 Platelet-derived growth factor (PDGF)-BB belongs to a fa

67 EDE levels of VCAM-1, von Willebrand factor, platelet-derived growth factor (PDGF)-BB, angiopoietin-1

68 rotid artery, and VSMCs were pretreated with platelet-derived growth factor (PDGF)-BB.

69 angiogenic factors, friend of Gata 2 (FOG2), platelet-derived growth factor (PDGF)-beta, and phosphat

70 We have identified platelet-derived growth factor (PDGF)-CC as a potent pro

71 e discovery of a novel ligand for PDGFRbeta, platelet-derived growth factor (PDGF)-DD, opened the pos

72 Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes

73 d quiescent mesenchymal cell activation in a platelet-derived growth factor (PDGF)-dependent manner.

74 Here, we present two novel platelet-derived growth factor (PDGF)-driven mouse model

75 ells (HASMCs); effect of Sema3E on basal and platelet-derived growth factor (PDGF)-induced proliferat

76 In damaged retina of flies and mice, platelet-derived growth factor (PDGF)-like signaling ind

77 or small interfering RNA knockdown decreased platelet-derived growth factor (PDGF)-mediated migration

78 c chambers that generate stable gradients of platelet-derived growth factor (PDGF).

79 highly sensitive and selective detection of platelet-derived growth factor (PDGF).

80 EC was uniformly inhibited by combined VEGF/platelet-derived growth factor (PDGF)/FGF receptor inhib

81 ular endothelial growth factor (VEGF) and 2) platelet-derived growth factor (PDGF-BB) in gingival cre

82 rCS3 binds the nerve growth factor (NGF) and platelet-derived growth factor (PDGF-BB), but the functi

83 Intravitreal injection of platelet-derived growth factor -AA or -AB led to profoun

84 idence of and accelerated the development of platelet-derived growth factor -induced glioma in mice.

85 rbor an activating mutation in either KIT or platelet-derived growth factor A ( PDGFRA).

86 r receptor alpha (PDGFRalpha) and its ligand platelet-derived growth factor A (PDGF-A) are co-express

87 In addition, platelet-derived growth factor A (PDGFA) was overexpress

88 n activating gene mutations in either KIT or platelet-derived growth factor A (PDGFRA).

89 The membrane-bound receptor for platelet-derived growth factor A (PDGFRalpha) is crucial

90 ast differentiation through the secretion of platelet-derived growth factor AA (PDGF-AA).

91 s (angiopoietin 2; hepatocyte growth factor; platelet-derived growth factor AA and BB; placental grow

92 tor, vascular endothelial growth factor, and platelet-derived growth factor AB) before and after comp

93 line lung/liver SUVmax index correlated with platelet-derived growth factor AB.

94 These cells expressed platelet-derived growth factor alpha and high transcript

95 1, and transiently suppressed myofibroblast platelet-derived growth factor alpha differentiation mar

96 a similar level of TNF-alpha, TGF-beta1, and platelet-derived growth factor alpha genes, and a high l

97 recursor activity in embryos was confined to platelet-derived growth factor alpha(+), myogenic factor

98 cts with HEUS and in untreated subjects with platelet-derived growth factor alpha-negative HES (n = 2

99 ynthesis, which required the late release of platelet-derived growth factor and COX-2 mRNA stabilizat

100 Platelet-rich plasma (PRP) consists of platelet-derived growth factor and transforming growth f

101 Because platelet-derived growth factor B (PDGF-B) signaling has

102 morphogen sonic hedgehog (Shh) is driven by platelet-derived growth factor B (PDGF-BB) in vascular s

103 ar endothelial growth factor A (VEGF-A), and platelet-derived growth factor B chain (PDGF-BB), to sti

104 nd AKT and compared them to oligodendroglial platelet-derived growth factor B-induced tumors in Ctv-a

105 h, we demonstrate that two of these pathways-platelet-derived growth factor BB (PDGF BB) and neural p

106 We first identified Shh as a target of platelet-derived growth factor BB (PDGF-BB) and found th

107 ed a fibronectin peptide (P12) that can bind platelet-derived growth factor BB (PDGF-BB) and promote

108 Growth factors, such as platelet-derived growth factor BB (PDGF-BB) and transfor

109 ulated by ECFC-derived paracrine factors via platelet-derived growth factor BB (PDGF-BB)/platelet-der

110 study participants, the angiogenic cytokine platelet-derived growth factor BB glycoprotein correlate

111 Two weeks after AMI, increased PB platelet-derived growth factor BB glycoprotein was assoc

112 (VWF), glutathione peroxidase 3 (GPX3), and platelet-derived growth factor beta (PDGFB).

113 nds to the transmembrane domain (TMD) of the platelet-derived growth factor beta receptor (PDGFbetaR)

114 d cells by forming a stable complex with the platelet-derived growth factor beta receptor transmembra

115 nteract with the transmembrane domain of the platelet-derived growth factor beta-receptor and specifi

116 fibroblast haptotaxis on fibronectin but not platelet-derived growth factor chemotaxis.

117 odeling linked to maximal thrombospondin and platelet-derived growth factor D expression.

118 phages, T cells, and platelets and increased platelet-derived growth factor D, Pdgfrb, Itga2, and mat

119 We find that platelet-derived growth factor evokes transient oxidatio

120 cell neuroprotection, with factors from the platelet-derived growth factor family being the most pot

121 f activated T cells, epidermal growth factor/platelet-derived growth factor family members, Wnt/beta-

122 Two of these loci flank the canine platelet-derived growth factor gene, which affects bone

123 ulture self-assembled into microvessels, and platelet-derived growth factor had chemotactic effect on

124 on into brains of mice engineered to express platelet-derived growth factor in the central nervous sy

125 Furthermore, platelet-derived growth factor may represent an independ

126 razin-2(1H)-ones toward potent and effective platelet-derived growth factor receptor (PDGF-R) beta-in

127 ng fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and inte

128 It activates platelet-derived growth factor receptor (PDGFR) beta in

129 st growth factor receptor (FGFR) family, the platelet-derived growth factor receptor (PDGFR) family,

130 Platelet-derived growth factor receptor (PDGFR) senses e

131 YR mice had significantly reduced amounts of platelet-derived growth factor receptor (PDGFR), which i

132 platelet-derived growth factor BB (PDGF-BB)/platelet-derived growth factor receptor (PDGFR)-beta sig

133 isib also inhibited ALL proliferation in ABL/platelet-derived growth factor receptor (PDGFR)-mutant m

134 l stromal tumor (GIST) cells overexpress the platelet-derived growth factor receptor (PDGFR)A, althou

135 Anterograde transport mutants display low platelet-derived growth factor receptor (PDGFR)alpha lev

136 Nkx2.2 can directly bind to the promoter of platelet-derived growth factor receptor alpha (Pdgfra) a

137 GG), often in association with TP53 loss and platelet-derived growth factor receptor alpha (PDGFRA) a

138 Here, we show an essential role for platelet-derived growth factor receptor alpha (Pdgfra) i

139 -oncogene receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor alpha (PDGFRA) m

140 errations in FLT3, tyrosine kinase 2 (TYK2), platelet-derived growth factor receptor alpha (PDGFRA),

141 Here, we show that platelet-derived growth factor receptor alpha (PDGFRalph

142 VEGF enhanced the viability of platelet-derived growth factor receptor alpha (PDGFRalph

143 Platelet-derived growth factor receptor alpha (PDGFRalph

144 many different signaling pathways, including platelet-derived growth factor receptor alpha (PDGFRalph

145 Here we report that platelet-derived growth factor receptor alpha (PDGFRalph

146 In this study, we isolated Platelet-derived growth factor receptor alpha (PDGFRalph

147 ellular origin of new myelin by fate mapping platelet-derived growth factor receptor alpha (PDGFRalph

148 a poor prognosis and exhibit an increase in platelet-derived growth factor receptor alpha (PDGFRalph

149 Platelet-derived growth factor receptor alpha (PDGFRalph

150 that TAg expression reduces the abundance of platelet-derived growth factor receptor alpha (PDGFRalph

151 ssed in primitive stromal cells that express platelet-derived growth factor receptor alpha and Sca-1

152 SMCs), interstitial cells of Cajal (ICC) and platelet-derived growth factor receptor alpha positive (

153 more, oncogenic RAB35 is sufficient to drive platelet-derived growth factor receptor alpha to LAMP2-p

154 ating with an increase in Il-6 expression in platelet-derived growth factor receptor alpha(+) mesench

155 differentiated alpha-smooth muscle actin(+)/platelet-derived growth factor receptor alpha(+)/CD44(+)

156 racterized by activating mutations of KIT or platelet-derived growth factor receptor alpha(PDGFRA), w

157 roblast growth factor receptors 1 through 4, platelet-derived growth factor receptor alpha, RET, and

158 atrix by increasing nonmuscle myosin II- and platelet-derived growth factor receptor alpha-mediated c

159 ntramuscular interstitial cells of Cajal and platelet-derived growth factor receptor alpha-positive c

160 ribution to vitreal bioactivity occurred via platelet-derived growth factor receptor alpha.

161 otes PVR by a noncanonical ability to engage platelet-derived growth factor receptor alpha.

162 press the mesenchymal stem cell (MSC) marker platelet-derived growth factor receptor alpha; hence, we

163 N, resulting in increased phosphorylation of platelet-derived growth factor receptor and activation o

164 (NOXs), and oxidized SHP2 co-localizes with platelet-derived growth factor receptor and NOX1/4.

165 factor receptor, heat shock protein 90, and platelet-derived growth factor receptor as well as mutua

166 ling and functional screening identified the platelet-derived growth factor receptor b (PDGFRb) as bo

167 ranscriptional response to Mucorales reveals platelet-derived growth factor receptor B (PDGFRB) signa

168 n profiling, which revealed up-regulation of platelet-derived growth factor receptor beta (Pdgfrb) an

169 protein Sestrin 2 (Sesn2) as a suppressor of platelet-derived growth factor receptor beta (Pdgfrbeta)

170 MEFs show slower kinetics of ligand-induced platelet-derived growth factor receptor beta (PDGFRbeta)

171 he overexpression and excessive signaling of platelet-derived growth factor receptor beta (PDGFRbeta)

172 We show that LOX activates Akt through platelet-derived growth factor receptor beta (PDGFRbeta)

173 Mesenchymal cells expressing platelet-derived growth factor receptor beta (PDGFRbeta)

174 Aberrant platelet-derived growth factor receptor beta (PDGFRbeta)

175 Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor beta and can cro

176 in 2 (IGFBP-2), nerve growth factor (b-NGF), platelet-derived growth factor receptor beta polypeptide

177 erved in a laser-induced model of CNV that a platelet-derived growth factor receptor beta positive (P

178 FDCs arise from perivascular platelet-derived growth factor receptor beta(+) precurso

179 gnificantly more NIK(+) ECs and perivascular platelet-derived growth factor receptor beta(+) preFDCs,

180 g., expression of alpha smooth muscle actin, platelet-derived growth factor receptor beta, desmin, vi

181 l665Ala variant in PDGFRB, which encodes the platelet-derived growth factor receptor beta.

182 structure provides a first glimpse into how platelet-derived growth factor receptor ECD, upon ligand

183 vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibitor PTK787

184 he vascular endothelial growth factor (VEGF)/platelet-derived growth factor receptor inhibitor suniti

185 ntibody or with small molecule inhibitors of platelet-derived growth factor receptor kinase or downst

186 tivation by a receptor activation loop (from platelet-derived growth factor receptor, a receptor tyro

187 lial cells and interstitial cells expressing platelet-derived growth factor receptor, alpha polypepti

188 ced RNA of epidermal growth factor receptor, platelet-derived growth factor receptor, and c-Met.

189 xpressing cells, nestin-expressing cells and platelet-derived growth factor receptor-alpha (PDGFR-alp

190 progenitors expressing a mesodermal marker, platelet-derived growth factor receptor-alpha (PDGFRA),

191 ell lines revealed co-activation of HER2 and platelet-derived growth factor receptor-alpha (PDGFRalph

192 opulation (SP) phenotype, PECAM-1 (CD31) and platelet-derived growth factor receptor-alpha (PDGFRalph

193 could be identified with antibodies against platelet-derived growth factor receptor-alpha (PDGFRalph

194 and flow sorted to isolate cells expressing platelet-derived growth factor receptor-alpha and exclud

195 ssion pattern, manifest in downregulation of platelet-derived growth factor receptor-alpha and recipr

196 to stabilize detrusor excitability involving platelet-derived growth factor receptor-alpha positive (

197 ild-type or constitutively activated PDGFRA (platelet-derived growth factor receptor-alpha) under con

198 tyrosine kinases (RTKs) such as PDGFRalpha (platelet-derived growth factor receptor-alpha), which sh

199 Senescent cells were positive for platelet-derived growth factor receptor-alpha, vimentin,

200 alpha signaling was conditionally blocked in platelet-derived growth factor receptor-alpha-positive a

201 y, 2) connective tissue progenitor cells, 3) platelet-derived growth factor receptor-alpha-positive c

202 Connective tissue progenitor cells, platelet-derived growth factor receptor-alpha-positive c

203 nd dendritic spine formation through Rabex-5/platelet-derived growth factor receptor-beta (PDGFRbeta)

204 a significant decrease in the expression of platelet-derived growth factor receptor-beta, a tyrosine

205 eoglycan NG2, a co-receptor of integrins and platelet-derived growth factor receptor.

206 Our results identify the Snail-PTEN platelet-derived growth factor receptor/phosphatidylinos

207 structure of PDGFRbeta [a full-length human platelet-derived growth factor receptor], in complex wit

208 ne kinase activity of ABL1/BCR-ABL1 and KIT, platelet-derived growth factor receptors (PDGFRs), and t

209 Imatinib, a selective inhibitor of platelet-derived growth factor receptors, and anakinra,

210 of neuroprotective proteins and suggest that platelet-derived growth factor secretion in particular m

211 By its inhibitory effect on platelet-derived growth factor signaling, imatinib could

212 -vascular endothelial growth factor and anti-platelet-derived growth factor signaling.

213 Blockade of platelet-derived growth factor signalling with neutraliz

214 ively regulate G1 progression in response to platelet-derived growth factor stimulation.

215 fically, we show how this transducer enables platelet-derived growth factor to trigger (in vitro) the

216 SMILR was also altered by interleukin-1alpha/platelet-derived growth factor treatment, and HAS2 expre

217 proteins (four antibodies and the chemokine platelet-derived growth factor) and two monovalent prote

218 d non-responders including stem cell factor, platelet-derived growth factor, and interleukin-15.

219 flammatory cytokines, invade Matrigel toward platelet-derived growth factor, and resist hypoxia-induc

220 th factors, such as epidermal growth factor, platelet-derived growth factor, and Wnt; and hormones, s

221 ice, including interleukin-1beta (IL-1beta), platelet-derived growth factor, angiopoietin 2, insulin-

222 Platelet-derived growth factor, estrogen, and serotonin

223 factor, vascular endothelial growth factor, platelet-derived growth factor, interleukin (IL)-8, IL-1

224 the hepatic stellate cell (HSC) activators, platelet-derived growth factor, transforming growth fact

225 ine kinase ligands (epidermal growth factor, platelet-derived growth factor, vascular endothelial gro

226 o mediate the secretion of Pvf, a ligand for platelet-derived growth factor- and vascular endothelial

227 broblasts exhibit impaired responsiveness to platelet-derived growth factor-AA and sonic hedgehog, tw

228 e Boyden chamber and show that a gradient of platelet-derived growth factor-AB (PDGF-AB) expedites mi

229 sient treatment with AZA in combination with platelet-derived growth factor-AB converts primary somat

230 ), which when tethered to a surface acted as platelet-derived growth factor-BB (PDGF-BB) enhancers to

231 Here, we found that platelet-derived growth factor-BB (PDGF-BB) secreted by

232 sforming growth factor-alpha (TGF-alpha) and platelet-derived growth factor-BB (PDGF-BB) were reduced

233 the receptor tyrosine kinase (RTK) agonist, platelet-derived growth factor-BB (PDGF-BB)-induced p21C

234 rom the culture of fat with ROS or PGZ on i) platelet-derived growth factor-BB (PDGF-BB)-stimulated p

235 atrix derivative (EMD) and recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with beta-

236 e graft (CTG) (control) or recombinant human platelet-derived growth factor-BB + beta-tricalcium phos

237 tor-2, transforming growth factor-beta1, and platelet-derived growth factor-BB at 2 weeks compared wi

238 gration and fibronectin synthesis induced by platelet-derived growth factor-BB or TGF-beta2.

239 amel matrix derivative and recombinant human platelet-derived growth factor-BB plus beta-tricalcium p

240 s 200 ng of bone morphogenetic protein-2 and platelet-derived growth factor-BB that were eluted over

241 growth factor, interleukin 6, angiopoietin, platelet-derived growth factor-BB, placental growth fact

242 matory cytokines interferon gamma, IL-1, and platelet-derived growth factor-BB, which are not produce

243 Platelet-derived growth factor-beta (PDGFB) is a mitogen

244 despite constituting a small fraction of the platelet-derived growth factor-beta (PDGFRbeta)(+) cell

245 nsforming growth factor-beta [TGF-beta], and platelet-derived growth factor-beta [PDGF-beta]) and blo

246 pe I collagen, matrix metalloprotease-1, and platelet-derived growth factor-beta.

247 ein oxidation within cells, and suggest that platelet-derived growth factor-dependent "redoxosomes,"

248 es insight into the vascular architecture of platelet-derived growth factor-driven glioblastoma.

249 genetic deletion mutant in a mouse model of platelet-derived growth factor-induced malignant oligode

250 In vitro, RR6 inhibited platelet-derived growth factor-induced SMC proliferation

251 Cortistatin inhibited platelet-derived growth factor-stimulated proliferation

252 wing stimulation with interleukin-1alpha and platelet-derived growth factor.

253 CCN2 (connective tissue growth factor), and platelet-derived growth factor.

254 ascular endothelial growth factor (VEGF) and platelet-derived growth factor.

255 factor], sCD40L [soluble CD40 ligand], PDGF [platelet-derived growth factor], RANTES [regulated on ac

256 Platelet-derived growth factors (PDGF) have an ambiguous

257 Platelet-derived growth factors (PDGFs) and their recept

258 Thus, we establish platelet-derived HMGB1 as an important mediator of throm

259 atory diseases; however, the contribution of platelet-derived HMGB1 in thrombosis remains unexplored.

260 ecific ablation of HMGB1 and determined that platelet-derived HMGB1 is a critical mediator of thrombo

261 and hepatocytes suggested liver delivery of platelet-derived IDUA possibly via the clearance pathway

262 COMP) acts as a major endogenous plasma- and platelet-derived inhibitor of thrombin activity in vitro

263 In summary, a new neutrophil-activating platelet-derived lipid generated by COX-1 is presented t

264 In this review, we will discuss platelet and platelet-derived mediator interactions with the innate a

265 sponse to donor-specific antibodies and that platelet-derived mediators may be markers of evolving al

266 Platelet-derived microparticles (PMPs) are associated wi

267 Platelet-derived microparticles (PMPs) are involved in h

268 d electrochemical biosensor for detection of platelet-derived microparticles (PMPs), a major risk fac

269 rce microscopy (AFM) to quantify and qualify platelet-derived microparticles (PMPs), on the whole nan

270 positive material on fibres, suggesting that platelet-derived microparticles attach to fibrin.

271 ed proinflammatory function of platelets and platelet-derived microparticles.

272 ed by proteolysis and can be used to monitor platelet-derived microparticles.

273 We identified direct RNA targets of platelet-derived miR-24 in tumor cells, which included m

274 Thus, platelet-derived miRNAs transfer in vivo to tumor cells

275 In contrast, the ontologically related platelet-derived MPs (PMPs) cannot be taken up by HSPCs

276 plasma dramatically increases the number of platelet-derived MPs, contaminates the extracellular miR

277 tery occlusion after injury, indicating that platelet-derived MRP-14 directly regulates thrombosis.

278 of PAI-1 demonstrate a major contribution by platelet-derived PAI-1 in the treatment of lenti-miR-30c

279 Immunoblot assays for platelet-derived phosphorylated-eNOS (p-eNOS) and immuno

280 length found in platelets (60-100 mer), and platelet-derived polyP significantly augment the plasmin

281 XIa-dependent factor IX (FIX) activation, or platelet-derived polyP, respectively.

282 bute to thrombosis in animal models, whereas platelet-derived polyphosphate (polyP) may potentiate co

283 contain polyphosphate, and the secretion of platelet-derived polyphosphate has been associated with

284 tool to improve the therapeutic efficacy of platelet-derived proteins for wound healing.

285 Platelet-derived proteins incorporated into the coacerva

286 Here, we show that platelet-derived rather than tumor cell-derived signals

287 further promoting the luminal deposition of platelet-derived regulated on activation normal T cell e

288 solid tumors in humans and mice and transfer platelet-derived RNA, including miRNAs, to tumor cells i

289 In this context, platelet-derived serotonin (5-HT) has been identified as

290 nst hepatic IR through RIPC was dependent on platelet-derived serotonin.

291 that FXIa neutralized both endothelium- and platelet-derived TFPI by cleaving the protein between th

292 Finally, we demonstrate that platelet-derived TSP1 modulates arterial thrombosis in v

293 Finally, platelet-derived-TxA2 elicits a full neutrophil response

294 he naive FVIII null hemophilia A (HA) mouse, platelet-derived VIII prevents both a primary and memory

295 henne et al present data showing the role of platelet-derived von Willebrand factor (VWF) in mediatin

296 created mice with either endothelial VWF or platelet-derived VWF and examined each phenotype for ble

297 These data suggest that whereas platelet-derived VWF does not play a crucial role in hem

298 Mice with only platelet-derived VWF had defective hemostasis and defect

299 These data suggest that platelet-derived VWF plays a specific role in stroke pat

300 r intriguing findings were that mice lacking platelet-derived VWF, but with adequate endothelial VWF